Biomarker Responses during and after Treatment with Nesiritide Infusion in Patients with Decompensated Chronic Heart Failure | Zendy

Wayne L. Miller | Zendy; Karen Hartman | Zendy; Mary F. Burritt | Zendy; Daniel D. Borgeson | Zendy; John C. Burnett | Zendy; Allan S. Jaffe | Zendy

Open Access

Biomarker Responses during and after Treatment with Nesiritide Infusion in Patients with Decompensated Chronic Heart Failure

Author(s) -

Wayne L. Miller,

Karen Hartman,

Mary F. Burritt,

Daniel D. Borgeson,

John C. Burnett,

Allan S. Jaffe

Publication year - 2004

Publication title -

clinical chemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.705

H-Index - 218

eISSN - 1530-8561

pISSN - 0009-9147

DOI - 10.1373/clinchem.2004.041582

Subject(s) - nesiritide , heart failure , medicine , cardiology , biomarker , acute decompensated heart failure , intensive care medicine , natriuretic peptide , chemistry , biochemistry

Objective methods to assess the adequacy of medication therapy for patients with advanced heart failure are lacking. Serial measurements of biomarkers might be beneficial. Therapy guided by N-terminal pro-B-type natriuretic peptide (NT-proBNP) might be helpful because NT-proBNP should be lowered by therapies that decrease endogenous BNP secretion.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research